Рубрика
Blog
-
2023
-
NICE Recommends Vutrisiran for Transthyretin-Related Amyloidosis
-
Syros Gets Fast Track Status for Higher-Risk Myelodysplastic Syndrome Candidate
-
US FDA clears Transcenta’s IND for Rett syndrome treatment
-
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
-
FDA Grants Rare Pediatric Disease Designation to OR-449 for Treatment of Adrenocortical Carcinoma
-
Merck Finds Causes of Nitrosamine in Diabetes Drugs
-
NICE Recommends Vutrisiran for Transthyretin-Related Amyloidosis
-
Sun Pharma to Buy Concert Pharma, Gaining Potential Alopecia Areata Treatment
-
National Institutes of Health grant to fund Alzheimer’s research
-
Avidity Biosciences Gets Fast Track for Facioscapulohumeral Muscular Dystrophy